AstraZeneca Pharmaceuticals is a British-Swedish biopharmaceutical company that produces medications and treatments for various diseases, disorders and conditions. Founded in 1999 as a merger between Sweden’s Astra AB and the UK’s Zeneca Group, the company now has six major divisions: Oncology, Cardiovascular & Metabolic Diseases, Infection & Vaccines, Neuroscience & Respiratory, Renal & Gastroenterology and Primary Care. AstraZeneca focuses on development of drugs across a range of therapeutic areas including Oncology, Respiratory (including asthma and COPD), Inflammation, Autoimmunity, Cardiovascular/Metabolic diseases (such as type 2 diabetes) and Infection & Vaccines. With headquarters based at Cambridge Science Park in Cambridge, England; AstraZeneca also has offices located throughout North American regions such as United States, Canada and Mexico among others. Its global presence spans over 100 countries worldwide with its products reaching patients in more than 175 countries each year. Today the company’s markets are supported by 54 manufacturing sites around the world generating drug products for sale in nearly 130 markets internationally.
PO BOX 15437, WILMINGTON, DE 198505437